admin – Page 4202 – Get News Story

Triple Negative Breast Cancer FDA Approvals, Emerging Therapies, Pipeline Insights and Companies | DelveInsight

DelveInsight’s, “Triple Negative Breast Cancer Pipeline Insight” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline landscape. It covers the Triple Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Triple Negative Breast Cancer Pipeline. Dive into DelveInsight’s comprehensive report today! @ Triple Negative Breast Cancer Pipeline Outlook

Key Takeaways from the Triple Negative Breast Cancer Pipeline Report

In January 2025:- Merck Sharp & Dohme LLC- The purpose of this study is to evaluate the efficacy and safety of pembrolizumab (MK-3475) plus chemotherapy vs placebo plus chemotherapy as neoadjuvant therapy and pembrolizumab vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).
In January 2025:- AstraZeneca:- This is a Phase IB/II, 2-stage, open-label, multicenter study to determine the efficacy and safety of durvalumab in combination with novel oncology therapies (i.e. therapies designed for immune modulation) with or without paclitaxel and durvalumab + paclitaxel as first-line treatment in patients with metastatic triple negative breast cancer (TNBC). The study is designed to concurrently evaluate potential novel treatment combinations with clinical promise using a 2-stage approach. The study will use a Simon 2-Stage design to evaluate which cohorts may proceed to expansion.
In January 2025: Mabwell (Shanghai) Bioscience Co., Ltd.- This study is a Phase 2, open-label,multicenter study designed to evaluate the efficacy and safety of 9MW2821monotherapy or combined with PD-1 inhibitor in locally advanced or metastatic Triple-Negative Breast Cancer.
DelveInsight’s Triple Negative Breast Cancer Pipeline analysis depicts a robust space with 75+ active players working to develop 80+ pipeline treatment therapies.
The leading Triple Negative Breast Cancer Companies such as Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., Infinity Pharmaceuticals, HiberCell, Inc., Zenith Epigenetics, BioLite, Inc., Abbisko Therapeutics, Phoenix Molecular Designs, OncoTherapy Science, ModernaTX, Inc, and others.
Promising Triple Negative Breast Cancer Pipeline Therapies such as Nanosomal Docetaxel Lipid Suspension (75 mg/m2), Taxotere® (100 mg/m2), B013+Nab-Paclitaxel, ZEN003694, Talazoparib, Pembrolizumab, Sacituzumab Govitecan-hziy, Datopotamab Deruxtecan (Dato-DXd), and others.

Stay ahead with the most recent pipeline outlook for Triple Negative Breast Cancer. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Triple Negative Breast Cancer Treatment Drugs

Triple Negative Breast Cancer Emerging Drugs Profile

Camrelizumab: Jiangsu HengRui Medicine

Camrelizumab (Airuika) is a humanized monoclonal antibody acts as immunomodulatory agent. It is formulated as solution for intravenous route. Camrelizumab is indicated as third-line treatment for recurrent or refractory classical hodgkin’s lymphoma, advanced hepatocellular carcinoma patients with oxaliplatin system chemotherapy, combined with pemetrexed and carboplatin for epidermal growth factor receptor (EGFR) gene mutation negative and anaplastic lymphoma kinase (ALK) negative, non-resectable locally advanced or metastatic first-line treatment of non-squamous non-small cell lung cancer (NSCLC), locally advanced or metastatic esophageal squamous cell carcinoma patients who have previously received first-line chemotherapy and whose disease has progressed or become intolerable and for the treatment of patients with advanced nasopharyngeal carcinoma who had disease progression after previous second-line and above chemotherapy or intolerable treatment. Currently the drug is in Phase III stage of Clinical trial evaluation for the treatment of Triple Negative Breast Cancer.

SKB264: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

SKB264 is an innovative TROP2-directed ADC which was developed by OptiDC, a well-known international ADC R&D platform of Kelun-Biotech, using a proprietary payload-linker strategy (Kthiol design strategy) that achieves an optimized balance of ADC safety and efficacy by combining novel irreversible antibody conjugation chemistry, pH-sensitive payload release mechanisms, and site-specific moderately potent toxin molecules with a DAR of 7.4 (novel topoisomerase I inhibitors). SKB264 has received Breakthrough Therapy Designations (BTDs) from the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) for the treatment of locally advanced or metastatic triple-negative breast cancer.

AK117: Akeso Biopharma

AK117, independently developed by Akeso, is a next generation of humanized lgG4 anti-CD47 antibody without hemagglutination effect. AK117 can bind to CD47 expressed on tumor cells and block the interaction between CD47 and SIRPα, in order to enhance the phagocytic activity of phagocytes on tumor cells, thereby inhibiting the growth of tumors. Currently, the drug is in Phase II stage of clinical trial evaluation for the treatment of Triple Negative Breast Cancer.

PLX038: ProLynx

PLX038 is a long-acting prodrug of the topoisomerase 1 (Top1) inhibitor, SN-38, which is also the active component of anti-cancer agents irinotecan and the ADC SC. Top1 inhibitors cause DNA breaks and kill tumors that are unable to repair the damage. Previously, Curie researchers showed that about one-third of TNBC patients have defects in DNA damage repair, and should respond to an effective SN-38-based therapy (Coussy et al., 2020). In PLX038, SN-38 is covalently bound to a circulating nanoparticle and is slowly released to provide free SN-38 with a long half-life, low Cmax, and high exposure – important facets for optimal safety and efficacy. Importantly, in preclinical studies PLX038 was shown to accumulate and be retained in solid tumors, where it slowly releases its SN-38. Currently, the drug is in Phase II stage of clinical trial evaluation for the treatment of Triple Negative Breast Cancer.

PMD-026: Phoenix Molecular Designs

PhoenixMD’s lead candidate, PMD-026, is the first RSK inhibitor being developed for the treatment of TNBC. It is a pill that is convenient for patients as opposed to intravenous delivery, the mode most commonly used to deliver chemotherapy. PMD-026 was designed for TNBC because RSK2 was specifically identified as the key kinase that drives the growth of this breast cancer subtype5, 6. PMD-026 is well-tolerated in breast cancer patients and can stop tumor growth for up to 5 months based on Phase 1 data. PFS in women with TNBC is three times longer for patients that express high levels of RSK2 activation as compared to those with low RSK2 activation. Preclinical data shows PMD-026 has the potential to be a platform technology for chemotherapy, hormone therapy and/or immunotherapy sensitization for a wide range of refractory cancers in the future. Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Triple Negative Breast Cancer.

Explore groundbreaking therapies and clinical trials in the Triple Negative Breast Cancer Pipeline. Access DelveInsight’s detailed report now! @ New Triple Negative Breast Cancer Drugs

Triple Negative Breast Cancer Companies

Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., Infinity Pharmaceuticals, HiberCell, Inc., Zenith Epigenetics, BioLite, Inc., Abbisko Therapeutics, Phoenix Molecular Designs, OncoTherapy Science, ModernaTX, Inc, and others

Triple Negative Breast Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

Oral
Parenteral
intravenous
Subcutaneous
Topical.

Triple Negative Breast Cancer Products have been categorized under various Molecule types such as

Monoclonal Antibody
Peptides
Polymer
Small molecule
Gene therapy

Unveil the future of Triple Negative Breast Cancer Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Triple Negative Breast Cancer Market Drivers and Barriers

Scope of the Triple Negative Breast Cancer Pipeline Report

Coverage- Global
Triple Negative Breast Cancer Companies- Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., Infinity Pharmaceuticals, HiberCell, Inc., Zenith Epigenetics, BioLite, Inc., Abbisko Therapeutics, Phoenix Molecular Designs, OncoTherapy Science, ModernaTX, Inc, and others.
Triple Negative Breast Cancer Pipeline Therapies- Nanosomal Docetaxel Lipid Suspension (75 mg/m2), Taxotere® (100 mg/m2), B013+Nab-Paclitaxel, ZEN003694, Talazoparib, Pembrolizumab, Sacituzumab Govitecan-hziy, Datopotamab Deruxtecan (Dato-DXd), and others.
Triple Negative Breast Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
Triple Negative Breast Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Get the latest on Triple Negative Breast Cancer Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Triple Negative Breast Cancer Companies, Key Products and Unmet Needs

Table of Content

Introduction
Executive Summary
Triple Negative Breast Cancer: Overview
Pipeline Therapeutics
Therapeutic Assessment
Triple Negative Breast Cancer – DelveInsight’s Analytical Perspective
Late Stage Products (Phase III)
Camrelizumab: Jiangsu HengRui Medicine
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
AK117: Akeso Biopharma
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
PMD-026: Phoenix Molecular Designs
Drug profiles in the detailed report…..
Inactive Products
Triple Negative Breast Cancer Key Companies
Triple Negative Breast Cancer Key Products
Triple Negative Breast Cancer- Unmet Needs
Triple Negative Breast Cancer- Market Drivers and Barriers
Triple Negative Breast Cancer- Future Perspectives and Conclusion
Triple Negative Breast Cancer Analyst Views
Triple Negative Breast Cancer Key Companies
Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/dyspepsia-market

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Triple Negative Breast Cancer FDA Approvals, Emerging Therapies, Pipeline Insights and Companies | DelveInsight

Hanley Investment Group Arranges Sale of Chipotle Mexican Grill and Starbucks Drive-Thru in Rancho Cucamonga, Calif., for $6.22 Million

RANCHO CUCAMONGA, Calif. – Hanley Investment Group Real Estate Advisors, a nationally recognized real estate brokerage and advisory firm specializing in retail property sales, announced today that the firm arranged the sale of two stand-alone buildings occupied by a Chipotle Mexican Grill and the adjacent Starbucks Drive-Thru in Rancho Cucamonga, California. The sales price was $6.22 million.

Hanley Investment Group’s Executive Vice Presidents Bill Asher and Jeff Lefko represented the seller, Chase Partners Ltd., based in Glendale, California. The buyer, a private investor based in Los Angeles, was represented by Shirley Kim at Epique Realty, also of Los Angeles.

The property involved a complete rehabilitation of the facility and the expansion of Starbucks by the developer, Chase Partners Ltd., a leading retail and industrial developer in Southern California since 1993. Chase is an active developer of Starbucks and Chipotle sites, as well as other name-brand retail developments, with a dozen projects currently underway. Michael Carter served as the project manager for Chase.

“We generated multiple qualified offers primarily from Southern California-based buyers and leveraged our extensive broker relationships to procure a repeat all-cash buyer, ensuring a smooth and timely closing by year-end,” said Asher.

Built in 2003, the two freestanding properties occupied by a 2,508-square-foot Chipotle Mexican Grill and a 4,000-square-foot Starbucks Drive-Thru sit on a 1.31-acre parcel located at 10811-10831 Foothill Boulevard, near the signalized intersection of Foothill Boulevard (U.S. Route 66 with over 32,000 cars per day) and Aspen Avenue.

Starbucks (NASDAQ: SBUX) recently signed a new 10-year extension, expanding into the adjacent 2,500-square-foot space for a total of 4,000 square feet, showing its continued long-term commitment to this location. The Rancho Cucamonga Starbucks is a top 15% location nationwide, based on customer traffic (Placer.ai). Starbucks is the largest coffee house chain globally, with approximately 40,199 stores in 84 countries, and Fortune ranked it as one of the “World’s Most Admired Companies” from 2009 to 2024.

Chipotle (NYSE: CMG) is ranked on the Fortune 500 and is recognized on Fortune’s Most Admired Companies 2024 list and Time Magazine’s Most Influential Companies. There are over 3,600 restaurants in the United States, Canada, the United Kingdom, France, Germany, and Kuwait and it is the only restaurant company of its size that owns and operates all its restaurants in North America and Europe.

According to Asher, Chipotle has nine years remaining on its lease, having recently extended early for five years, demonstrating its ongoing investment in the site. The Rancho Cucamonga Chipotle is a top 25% location in California, based on customer traffic (Placer.ai).

Chipotle and Starbucks are located across from Terra Vista Town Center, one of Rancho Cucamonga’s most established and premier regional shopping centers. The 645,000-square-foot Terra Vista Town Center is ranked within the top 25% of power centers nationwide, based on customer traffic, according to Placer.ai. The center is anchored by Target, Hobby Lobby, and LA Fitness, along with other national tenants including Ross Dress for Less, Michaels, HomeGoods, Panera Bread, Wells Fargo, CVS, Bank of America, and Five Below. The property is ideally situated in the center of the city within minutes of the 10, 15, and 215 freeways. The property is located next to Rancho Cucamonga’s 44 million square feet of office and industrial space, which combined employs over 65,000 employees.

The population of Rancho Cucamonga grew 53.5% from 2010 to 2020. Within one mile of the property, the population experienced a 317.8% growth in population from 2010 to 2020. More than 276,000 residents with an average household income in excess of nearly $113,000 are within a five-mile radius.

Asher added, “It was one of our most sought-after listings in 2024, receiving significant interest and activity from both buyers and brokers. The combination of two corporate leases with two of the most recognizable national credit QSR tenants in the U.S., both with a 21-year operating history at the site, made it a highly desirable investment.”

About Hanley Investment Group

Hanley Investment Group Real Estate Advisors is a real estate brokerage and advisory services company with an over $11 billion transaction track record that specializes in the sale of retail properties nationwide. Our expertise, proven track record, and unwavering dedication to putting clients’ needs first set us apart in the industry. Hanley Investment Group creates value by delivering exceptional results through the use of property-specific marketing strategies, cutting-edge technology, and local market knowledge. Our nationwide relationships with investors, developers, institutions, franchisees, brokers, and 1031 exchange buyers are unparalleled in the industry, translating into maximum exposure and pricing for each property. With unmatched service, Hanley Investment Group has redefined the experience of selling retail investment properties. For more information, visit www.hanleyinvestment.com.

Media Contact
Company Name: Hanley Investment Group Real Estate Advisors
Contact Person: Bill Asher, Executive Vice President
Email: Send Email
Phone: 949.585.7684
Address:3500 East Coast Highway, Suite 100
City: Corona del Mar
State: California
Country: United States
Website: https://hanleyinvestmentgroup.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hanley Investment Group Arranges Sale of Chipotle Mexican Grill and Starbucks Drive-Thru in Rancho Cucamonga, Calif., for $6.22 Million

Sveagle Plumbing Now Offers Professional Plumbing Service in Frisco

Frisco, TX – Sveagle Plumbing, a trusted name in the plumbing industry since 1969, is proud to announce its expanded services as a premier plumber in Frisco. With a commitment to excellence and customer satisfaction, Sveagle Plumbing offers a wide range of plumbing services to meet the diverse needs of Frisco residents and businesses.

Sveagle Plumbing has built a solid reputation as one of the best plumbers in Frisco, TX, providing top-quality plumbing solutions for over five decades. The company’s team of skilled technicians is equipped to handle everything from routine maintenance to complex plumbing problems, ensuring that customers receive reliable and efficient service.

Mitch Kenney, spokesperson for Sveagle Plumbing, stated, “We are thrilled to extend our services to the Frisco community. Our team is dedicated to delivering exceptional plumbing solutions that not only meet but exceed our customers’ expectations. We understand the importance of prompt and professional service when it comes to plumbing issues, and we’re committed to being the go-to plumber in Frisco that residents can trust.”

As a leading provider of plumbing services in Frisco, Sveagle Plumbing offers a comprehensive suite of solutions, including water heater repair, drain cleaning, leak detection, and emergency plumbing services. The company’s technicians are highly trained and equipped with state-of-the-art tools to diagnose and resolve plumbing problems efficiently.

One of the key factors that sets Sveagle Plumbing apart from other plumbers in Frisco, TX, is their commitment to transparency and fair pricing. The company offers free estimates and flat-rate pricing, ensuring that customers know the exact cost of the job upfront, with no hidden fees or surprises.

Sveagle Plumbing’s expansion into the Frisco area is a testament to their growth and dedication to serving more communities in Texas. The company’s reputation for quality workmanship and exceptional customer service has made them a preferred choice for both residential and commercial plumbing needs.

For those seeking plumbing services in Frisco, TX, Sveagle Plumbing offers 24/7 emergency support, providing peace of mind to customers facing urgent plumbing issues. Their team of experienced technicians is always ready to respond promptly to any plumbing emergency, minimizing damage and restoring normalcy as quickly as possible.

Sveagle Plumbing’s commitment to excellence extends beyond their technical expertise. The company places a strong emphasis on customer education, helping clients understand their plumbing systems and providing valuable tips for maintenance and prevention of future issues. This approach not only solves immediate problems but also helps customers save money in the long run by avoiding potential plumbing disasters.

As part of their dedication to the Frisco community, Sveagle Plumbing is actively involved in local initiatives and supports various community programs. The company believes in giving back to the areas they serve, further solidifying their position as a trusted local plumbing business

With their expansion into Frisco, Sveagle Plumbing is poised to become the go-to plumbing service in the area. Their combination of experience, expertise, and customer-focused approach makes them an ideal choice for anyone in need of reliable plumbing solutions.

Residents and businesses in Frisco can now benefit from Sveagle Plumbing’s professional services, joining the long list of satisfied customers who have experienced the company’s commitment to quality and excellence.

For more information, please contact Mitch Kenney at +19704805031.

About Sveagle Plumbing:

Sveagle Plumbing is a leading plumbing company serving Frisco and surrounding areas in Texas. With over five decades of experience, Sveagle Plumbing has built a reputation for providing high-quality plumbing services, exceptional customer care, and innovative solutions to complex plumbing problems. The company’s team of licensed technicians is dedicated to delivering prompt, reliable, and efficient plumbing services to both residential and commercial clients.

Media Contact
Company Name: Sveagle Plumbing
Contact Person: Mitch Kenney
Email: Send Email
Phone: +19704805031
Address:619 Main St #4A
City: Frisco
State: CO
Country: United States
Website: https://sveagle.com/

Certificate Hero Revolutionizes Insurance Certificate Management with Gen AI-Powered Upgrade

Dedham, MA – In a significant development poised to change the insurance industry, Certificate Hero has unveiled a major upgrade to its innovative Contract Analysis platform. This enhancement brings remarkable improvements in certificate generation and issuance, placing Certificate Hero at the forefront of AI-driven insurance solutions.

As the insurance sector rapidly adapts, with more than 50% of insurers incorporating artificial intelligence in various ways, Certificate Hero’s latest upgrade meets the increasing need for efficiency and precision in managing insurance certificates. The company’s SaaS solution enables insurance brokers, carriers, and their clients to effortlessly issue and manage certificates of insurance from beginning to end.

Key features of the upgrade include:

1. Enhanced AI Model: Utilizing advanced artificial intelligence, the new model quickly and accurately identifies and extracts insurance-related requirements from searchable and non-searchable contracts.

2. Intuitive Multi-View Navigation: Improved workflows with better comparison capabilities between contract requirements and policy coverages enhance the user experience.

3. Unified Contract Examination: A single-view interface with Quick Find functionality allows users to easily review important sections of contracts.

4. AI-Powered Q&A: By leveraging the new model and the capabilities of artificial intelligence, users can now extract data and receive immediate answers to questions regarding the contract.

“Our latest upgrade represents a major step forward in managing insurance certificates,” said Michael Yanoff, CEO of Certificate Hero. “By harnessing the power of AI and machine learning, we’re enhancing efficiency and changing the way insurance professionals interact with complex contract data.” This innovation aligns with industry trends, as insurers are increasingly adopting AI for predictive analytics, risk modelling, and better customer insights. Certificate Hero’s platform addresses these demands by providing a comprehensive solution that saves time, reduces errors, and ensures the issuance of the most accurate certificates in the most efficient way possible.

As the insurance industry increasingly adopts digital transformation, the Certificate Hero platform establishes a new benchmark for AI-driven solutions. By merging advanced technology with a focus on user experience, Certificate Hero is set to spearhead the transformation of insurance certificate management for the foreseeable future.

For more details about Certificate Hero and its groundbreaking platform, visit https://certificatehero.com

Media Contact
Company Name: Certificate Hero
Contact Person: Michael Yanoff
Email: Send Email
Country: United States
Website: https://certificatehero.com

Carlsbad Auto Service Supports Foster Care Youth With Generous Donation

Carlsbad Auto Service Continues to Champion Foster Kids and Community Success

Carlsbad, CA – Carlsbad Auto Service, a proud supporter of Walden Family Services, continues its commitment to fostering positive change in the community by supporting foster care youth. Owned and operated by a dynamic team of women, Carlsbad Auto Service promotes success and empowerment for young women and aspiring young mechanics alike.

Meet Isaiah, an inspiring young man whose journey is a testament to resilience and hope. Growing up in foster care from the age of seven, Isaiah faced incredible challenges, including being placed in over 30 homes. Despite this instability, he found a loving and supportive foster home where he lived for two years and graduated from Adelanto High School with honors.

At 18, Isaiah joined Walden’s Transitional Housing Program (THP) and worked tirelessly to stabilize his life. Through sheer determination, he overcame obstacles like limited family support and transportation issues. Even in the face of these challenges, Isaiah stayed committed to providing for his son, maintaining his job, and remaining in good standing with the THP program.

But Isaiah’s story doesn’t end there. Thanks to the generous support of Carlsbad Auto Service, Isaiah now has reliable transportation! Carlsbad Auto Service recently donated two vehicles to Walden Family Services, and Isaiah was the proud recipient of a fixed-up Toyota 4Runner. This invaluable gift has not only provided Isaiah with the means to maintain his job and care for his son but has also given him the flexibility to explore further education and pursue his dream of joining the Navy.

“We believe in giving back to our community and supporting foster youth like Isaiah,” said Jaime Sanders, co-owner of Carlsbad Auto Service. “Fixing up cars and donating them to foster kids is just one way we can make a positive impact. Seeing Isaiah’s determination and knowing that our efforts can help him achieve his dreams is incredibly rewarding.”

“At Carlsbad Auto Service, we believe that every young person deserves a chance to thrive,” said Eva Papousek, co-owner of Carlsbad Auto Service. “By donating vehicles and providing practical support, we hope to empower foster youth like Isaiah to take control of their futures. It’s not just about the cars; it’s about creating opportunities and making a meaningful difference in our community.”

Carlsbad Auto Service has a longstanding history of supporting Walden Family Services through generous donations and active involvement in fundraising efforts over the past few years. Their commitment to the community ensures positive effects that extend beyond car donations, promoting success and independence for foster youth and others.

Isaiah’s story embodies the power of resilience, dedication, and the incredible impact of community support. His journey is a shining example of what can be achieved with the right support and opportunities.

Carlsbad Auto Service’s dedication to the community and foster care is truly making a difference. Their continuous support of Walden Family Services and foster kids ensures that young individuals like Isaiah have the resources they need to build a brighter future.

For more information on how you can support Walden Family Services and make a difference in the lives of foster care youth, please visit Walden Family Services.

About Carlsbad Auto Service:

Carlsbad Auto Service is a woman-owned business that prides itself on delivering top-notch auto repair services while supporting community initiatives. Their commitment to excellence and community welfare sets them apart as a beacon of positive change in Carlsbad. Learn more at: www.carlsbadautoservice.com.

About Walden Family Services:

Established in 1976, Walden Family Services focuses on providing critical support to foster children, youth, and adoptive families across Southern California. Through diverse programs and initiatives, Walden aims to create stable, nurturing environments that enable children and young adults in need to thrive and realize their full potential.

Media Contact
Company Name: Walden Family Services
Contact Person: Shannon Lynard
Email: Send Email
Phone: +16195845777
Address:8525 Gibbs Dr #100
City: San Diego
State: CA
Country: United States
Website: https://waldenfamily.org/locations/corporate-office-san-diego/

Alzheimer’s Disease FDA Approvals, Clinical Trials, Emerging Drugs, Pipeline Insights and Companies | DelveInsight

DelveInsight’s, “Alzheimer’s Disease Pipeline Insight” report provides comprehensive insights about 110+ companies and 120+ pipeline drugs in Alzheimer’s-disease pipeline landscape. It covers the Alzheimer’s Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Alzheimer’s Disease therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore the comprehensive insights by DelveInsight and stay ahead in understanding the Alzheimer’s Disease Treatment Landscape. Click here to read more @ Alzheimer’s Disease Pipeline Outlook

Key Takeaways from the Alzheimer’s Disease Pipeline Report

In January 2025:- Novo Nordisk- The study is being conducted to understand how the medicine, semaglutide, affects the immune system and other biological processes in people with Alzheimer’s disease. Semaglutide is a medicine that doctors can prescribe in some countries for the treatment of type 2 diabetes and excess body weight.
In January 2025:- Hoffmann-La Roche:- The purpose of this study is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics, and pharmacodynamics of multiple-ascending intravenous (IV) doses of RO7126209 in participants with prodromal or mild to moderate Alzheimer’s disease (AD), who are amyloid positive based on amyloid positron emission tomography (PET) scan.
In January 2025:- Bigespas Ltd:- Multicenter Randomized Double-blind Placebo-controlled Three-arm Parallel-group Clinical Study to Evaluate the Efficacy and Safety of DMB-I in the Treatment of Dementia Associated With Alzheimer’s Disease. The purpose of this study is to assess the efficacy and safety of DMB-I for the treatment of patients with Alzheimer type dementia.
In January 2025:- Eisai Inc.:- The primary objective of the study is to determine the dose response of E2814, when concurrently administered with lecanemab, on the change from baseline at 6 months in cerebrospinal fluid (CSF) microtubule-binding region (MTBR)-tau-243 in participants with early Alzheimer’s disease (AD).
DelveInsight’s Alzheimer’s Disease pipeline report depicts a robust space with 110+ active players working to develop 120+ pipeline therapies for Alzheimer’s Disease treatment.
The leading Alzheimer’s Disease Companies such as AriBio Co., Ltd., Eli Lilly & Co., Cognition Therapeutics, AbbVie Inc., Allyx Therapeutics, Inc., Cassava Sciences, BioVie Inc., Novo Nordisk, Alector Inc., Longeveron Inc., TrueBinding, Inc., VT BIO, Luye Pharma Group Ltd., Lexeo Therapeutics, Merck Sharp & Dohme LLC, Regeneration Biomedical, Alnylam Pharmaceuticals, Sinotau Pharmaceutical Group, Eisai Inc., Shanghai Hengrui Pharmaceutical Co., Ltd and others.
Promising Alzheimer’s Disease Therapies such as Aricept, INM-176, SAR110894, Donepezil, CPC-201, ENA713, Remternetug, and others.

Stay informed about the cutting-edge advancements in Alzheimer’s Disease treatments. Download for updates and be a part of the revolution in care @ Alzheimer’s Disease Clinical Trials Assessment

Alzheimer’s Disease Emerging Drugs Profile

AR1001: AriBio Co., Ltd.

AR1001 is a selective inhibitor of phosphodiesterase 5. This new pyrrolo-pyrimidinone was first developed for treatment of erectile dysfunction in South Korea, and is now being tested for Alzheimer’s Disease. Its maker claims AR1001 to be 10-fold more potent at inhibiting PDE5, and better at entering the brain, than approved PDE5 inhibitors, including sildenafil.

NE3107: BioVie

NE3107 is an orally available small molecule with potential anti-inflammatory and insulin-sensitizing properties that can cross the blood-brain barrier. It was originally developed by NeurMedix and acquired by BioVie in April. The experimental molecule works by blocking the activation of two major regulators of inflammatory pathways: extracellular signal regulated kinase (ERK) and nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB).

LY3372689: Eli Lilly & Co.

LY3372689 is an orally active O-GlcNAcase (OGA) enzyme inhibitor. O-GlcNAcylation, i.e., addition of N-acetylglucosamine to serine and threonine residues, is a post-translational modification that regulates the function of many proteins. In particular, N-GlcNAcylation of tau reduces its propensity to form toxic aggregates. OGA catalyzes removal of O-GlcNAc. OGA inhibitors promote tau glycosylation, prevent aggregation, and appear to stabilize tau in a soluble, nonpathogenic form. LY3372689 can be used for tauopathies research, including Alzheimer’s disease. Currently the drug is in Phase II stage of Clinical trial evaluation for the treatment of Alzheimer’s disease.

CT1812: Cognition Therapeutics

Cognition Therapeutics isdeveloping CT1812, an oral, brain-penetrant, small molecule therapeutic, which has been shown to protect neurons and synapses by preventing the binding of toxic oligomers. CT1812 acts as a neuroprotective agent both by shielding neurons and synapses from oligomer binding and by preventing oligomers from attaching to synapses in the first place. CT1812 may help mitigate the neurotoxic effects, slowing cognitive decline and progression of Alzheimer’s disease. Currently, the drug is in the Phase II stage of development to treat Alzheimer’s-disease.

ABBV-916: AbbVie Inc.

ABBV-916 anti-AβpE3 (N-terminal truncated, pyroglutamate-modified at amino acid position 3, amyloid beta) is a monoclonal antibody being investigated for the treatment of Alzheimer’s Disease. The drug candidate is administered through intravenous route as an infusion. Currently, the drug is in the Phase II stage of development to treat Alzheimer’s-disease.

ALX-001: Allyx Therapeutics, Inc.

ALX-001 (previously BMS-984923) is a silent allosteric modulator of mGluR5, a first-in-class compound that selectively blocks the pathogenic activation of the receptor while preserving the physiological glutamate signaling that is required for normal cognition. ALX-001 has a wide therapeutic window that can saturate receptor binding while avoiding on-target toxicity observed with negative allosteric modulators. Currently, the drug is in the Phase I stage of development to treat Alzheimer’s disease.

Learn more about Alzheimer’s Disease Drugs opportunities in our groundbreaking Alzheimer’s Disease research and development projects @ Alzheimer’s Disease Unmet Needs

Alzheimer’s Disease Companies

AriBio Co., Ltd., Eli Lilly & Co., Cognition Therapeutics, AbbVie Inc., Allyx Therapeutics, Inc., Cassava Sciences, BioVie Inc., Novo Nordisk, Alector Inc., Longeveron Inc., TrueBinding, Inc., VT BIO, Luye Pharma Group Ltd., Lexeo Therapeutics, Merck Sharp & Dohme LLC, Regeneration Biomedical, Alnylam Pharmaceuticals, Sinotau Pharmaceutical Group, Eisai Inc., Shanghai Hengrui Pharmaceutical Co., Ltd and others.

Alzheimer’s-disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

Oral
Intravenous
Subcutaneous
Parenteral
Topical

Alzheimer’s Disease Products have been categorized under various Molecule types such as

Recombinant fusion proteins
Small molecule
Monoclonal antibody
Peptide
Polymer
Gene therapy

Discover the latest advancements in Alzheimer’s Disease treatment by visiting our website. Stay informed about how we’re transforming the future of neurology @ Alzheimer’s Disease Market Drivers and Barriers, and Future Perspectives

Scope of the Alzheimer’s Disease Pipeline Report

Coverage- Global
Alzheimer’s Disease Companies- AriBio Co., Ltd., Eli Lilly & Co., Cognition Therapeutics, AbbVie Inc., Allyx Therapeutics, Inc., Cassava Sciences, BioVie Inc., Novo Nordisk, Alector Inc., Longeveron Inc., TrueBinding, Inc., VT BIO, Luye Pharma Group Ltd., Lexeo Therapeutics, Merck Sharp & Dohme LLC, Regeneration Biomedical, Alnylam Pharmaceuticals, Sinotau Pharmaceutical Group, Eisai Inc., Shanghai Hengrui Pharmaceutical Co., Ltd and others.
Alzheimer’s Disease Therapies- Aricept, INM-176, SAR110894, Donepezil, CPC-201, ENA713, Remternetug, and others.
Alzheimer’s Disease Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
Alzheimer’s Disease Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of Alzheimer’s Disease Pipeline on our website @ Alzheimer’s Disease Emerging Drugs and Companies

Table of Content

Introduction
Executive Summary
Alzheimer’s-disease: Overview
Pipeline Therapeutics
Therapeutic Assessment
Alzheimer’s-disease– DelveInsight’s Analytical Perspective
Late Stage Products (Phase III)
AR1001: AriBio Co., Ltd.
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
LY3372689: Eli Lilly & Co.
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
ALX-001: Allyx Therapeutics, Inc.
Drug profiles in the detailed report…..
Preclinical and Discovery Stage Products
Drug name: Company name
Drug profiles in the detailed report…..
Inactive Products
Alzheimer’s-disease Key Companies
Alzheimer’s-disease Key Products
Alzheimer’s-disease- Unmet Needs
Alzheimer’s-disease- Market Drivers and Barriers
Alzheimer’s-disease- Future Perspectives and Conclusion
Alzheimer’s-disease Analyst Views
Alzheimer’s-disease Key Companies
Appendix

About Us

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Alzheimer’s Disease FDA Approvals, Clinical Trials, Emerging Drugs, Pipeline Insights and Companies | DelveInsight

Licensed Medicare Insurance Brokers in Fresno Now Provided by Local Medicare Agents – LMA Insurance

Local Medicare Agents – LMA Insurance, a leading provider of Medicare insurance services, has expanded its offerings to include comprehensive Medicare insurance brokerage services in Fresno, California. This development comes as a response to the growing need for personalized Medicare guidance and support in the area.

As the Medicare landscape continues to evolve, many seniors in Fresno find themselves overwhelmed by the complexity of available options. LMA Insurance aims to address this challenge by providing expert guidance through their team of experienced Medicare insurance brokers.

Robert Loys, partner for LMA Insurance stated, “We’re excited to bring our specialized Medicare brokerage services to Fresno. Our team is committed to helping seniors navigate the intricate world of Medicare with confidence, ensuring they find the coverage that best suits their unique healthcare needs and budget.”

LMA Insurance’s Medicare brokers in Fresno offer a wide range of services, including assistance with Medicare Advantage plans, Medicare Supplement plans, and Medicare Part D coverage. Their approach is rooted in education, ensuring that clients fully understand their options before making decisions.

One of the key benefits of working with a Medicare insurance broker in Fresno is the access to unbiased advice. Unlike agents who may represent specific insurance companies, brokers can offer a comprehensive view of available plans from multiple providers. This allows seniors to make informed decisions based on their individual circumstances.

The expansion of Medicare brokerage services in Fresno comes at a crucial time, as many residents are preparing for the upcoming Medicare enrollment period. LMA Insurance’s brokers are well-equipped to guide seniors through this process, helping them avoid common pitfalls and ensuring they secure the most appropriate coverage.

In addition to assisting with plan selection, LMA Insurance’s Medicare brokers in Fresno also provide ongoing support to their clients. This includes help with understanding benefits, resolving claims issues, and navigating changes in coverage as needs evolve over time.

The company’s commitment to personalized service sets them apart in the Medicare insurance landscape. Each client receives individualized attention, with brokers taking the time to understand their specific health concerns, financial situation, and preferences before recommending plans.

LMA Insurance’s Medicare brokers are also well-versed in the local healthcare landscape of Fresno. This local expertise allows them to provide valuable insights into which plans offer the best access to preferred healthcare providers and facilities in the area.

The company’s expansion into Fresno’s Medicare insurance brokerage market is expected to have a positive impact on the community. By providing access to expert guidance, Local Medicare Agents – LMA Insurance aims to help more seniors in Fresno secure comprehensive, affordable healthcare coverage.

LMA Insurance’s Medicare brokers in Fresno are equipped to handle a variety of situations, from those new to Medicare to individuals looking to switch plans. They can provide assistance with Medicare enrollment, help compare different plans, and offer guidance on supplemental coverage options.

The company’s commitment to transparency is evident in their approach to discussing Medicare options. Brokers take the time to explain the costs associated with different plans, including premiums, deductibles, and out-of-pocket expenses, ensuring clients have a clear understanding of their financial responsibilities.

For more information please contact Robert Loyd at +15593664734.

About Local Medicare Agents – LMA Insurance:

Local Medicare Agents – LMA Insurance is a leading provider of Medicare insurance services, dedicated to helping seniors navigate the complexities of Medicare. With a team of experienced brokers and a commitment to personalized service, LMA Insurance offers comprehensive support for Medicare Advantage, Medicare Supplement, and Part D plans. Their education-focused approach ensures clients make informed decisions about their healthcare coverage.

Media Contact
Company Name: Local Medicare Agents – LMA Insurance
Contact Person: Robert Loyd
Email: Send Email
Phone: (559) 366-4734
Address:5446 N Palm Ave #105
City: Fresno
State: CA
Country: United States
Website: https://medicareu.com/locations/fresno/

They Love You Until You Start Thinking for Yourself by Monica Omorodion Swaida announced by OnlineBookClub’s CEO Scott Hughes as the February Book of the Month

An Inspiring Memoir Encouraging Open-Mindedness and Personal Empowerment.

United States – OnlineBookClub, a premier community dedicated to the love of reading, is thrilled to announce that “They Love You Until You Start Thinking for Yourself” by Monica Omorodion Swaida has been selected as the February Book of the Month. This compelling memoir chronicles Swaida’s remarkable journey from a humble immigrant to a successful entrepreneur and advocate for open-mindedness, embodying resilience, hard work, and determination.

In this thought-provoking autobiography, Swaida shares her experiences of navigating a new culture as an immigrant teenager and how she overcame adversity to achieve success in a male-dominated field. Her travels to over thirty countries enhanced her understanding of humanity’s universal intricacies and the complexities of cultural identity.

Scott Hughes, CEO of OnlineBookClub, remarked, “Monica’s memoir is more than just a personal narrative; it is a powerful call to action. In a world that often challenges our beliefs and perceptions, her story serves as a bridge that fosters understanding and empathy across cultural barriers. We are proud to spotlight a work that not only inspires but also fosters important conversations.”

Swaida herself reflects on her journey, saying, “In the end, if your end game is to win, then be prepared not to be lazy! I work about 14 hours daily. Many die on their way out and many succeed. It is crazy out there, but it is also so lovely. I want my readers to know that success is attainable, regardless of the obstacles you face.”

With reviews praising its authentic perspective on relationships, self-discovery, and empowerment, “They Love You Until You Start Thinking for Yourself” invites readers to confront their preconceptions and embrace a more inclusive worldview. It highlights the importance of open-heartedness, multi-dimensional thinking, and understanding the nuances of human nature -elements that resonate with many in today’s society.

As part of the celebration, OnlineBookClub is inviting all readers to join the discussion forum surrounding the book at Online Book Club Forum or follow the link https://forums.onlinebookclub.org/viewforum.php?f=329. This platform allows readers to share their thoughts, insights, and discussions, fostering a community engaged in meaningful dialogue about the themes presented in Swaida’s memoir.

About the Author

Monica Omorodion Swaida is a multi-talented and fearless entrepreneur, philanthropist, award-winning filmmaker, and actress. With an impressive career spanning various fields, she has made her mark as a motivational speaker and real estate investor, as well as the owner of a successful insurance company. Known by her stage name Monicazation, Swaida has shared the stage with legendary musicians and continues to inspire audiences with her creative endeavors. Recently, she premiered her latest film, “Bird in A Cage,” in the United States, along with the documentary “Tales of Our Legends,” which highlights Nigerian heroes from various walks of life. Swaida’s diverse experiences enrich her writing and empower her advocacy for open-mindedness and cultural understanding, making her a compelling voice in the literary landscape.

About OnlineBookClub.org

OnlineBookClub.org is a thriving online community that brings together readers from around the world to discuss, review, and celebrate literature of all genres. With a passion for fostering meaningful conversations around books, OnlineBookClub offers a platform for bibliophiles to connect, engage, and share their love for reading.

Media Contact
Company Name: Online Book Club
Contact Person: Scott Hughes
Email: Send Email
Country: United States
Website: https://onlinebookclub.org/

Drift Couriers’ Nationwide Same-Day Courier for B2B Logistics

Since its launch three years ago in London, Drift Couriers has proven that reliability, flexibility, and outstanding customer care can revolutionize modern logistics. The company stands out among competitors for its unwavering commitment to service excellence—one that encompasses affordable pricing, fast turnaround times, and consistent professionalism at every step of the journey.

With a nationwide same-day courier service, the company ensures timely pickups and drop-offs regardless of location—bustling Manchester, seaside Brighton, or a quieter spot like Exeter. A key driver of this success is Drift Couriers’ extensive network of experienced drivers who are always prepared to meet evolving customer demands. Each driver is strategically located across various cities and towns, enabling them to respond quickly to last-minute requests.

The company’s range of courier vehicle options supports various industries, providing a local courier service that handles everything from urgent legal documents to event equipment. Manufacturing, retail, and healthcare companies also benefit significantly, as Drift Couriers can manage supply chain logistics to ensure parcels and pallets reach their destinations on time.

By promising an average pickup time of 60 minutes, the company addresses the critical need for speed in modern business operations. In an era where customers expect faster and more reliable fulfilment, Drift Couriers’ commitment to prompt service has positioned the company as a top choice for clients who cannot afford delays. Drift Couriers have become a key partner in ensuring smooth, efficient operations—particularly crucial for retailers, legal firms, and healthcare providers working with sensitive materials or tight deadlines by seamlessly bridging the gap between businesses and their customers.

Many B2B customers rely on flexible shipping services to handle their specialized needs. Drift couriers offer a dedicated B2B Courier service focusing on strategic pick-ups and drop-offs, helping organizations streamline their shipping processes.

A key aspect of Drift Couriers’ offering is its medical courier service, which has garnered attention for its reliable handling of healthcare-related deliveries. Medical professionals and institutions can rest assured that sensitive items—like lab samples, medications, or equipment—will be delivered safely and per strict regulations.

The company has implemented eco-friendly delivery strategies, including grouping packages with similar destinations into a single vehicle, reducing total mileage, and shrinking its carbon footprint. By consolidating shipments in an organized manner, Drift Couriers minimizes unnecessary trips, helping to set a standard for environmentally conscious logistics in the UK.

To further serve diverse client needs, Drift Couriers offers day-hire services for organizations that require a dedicated van and driver for a specified period. This arrangement is particularly helpful for on-site events, film productions, or construction projects where multiple pickups and drop-offs are needed. In addition, the company provides specialized pallet shipping, which is especially beneficial for industries that deal with higher-volume or oversized shipments. Clients can book a courier delivery of pallets, from a single pallet to heavier loads that call for trucks in the 7.5-tonne to 18-tonne range, ensuring that weight capacities of up to 9500kg can be managed effectively.

While Drift Couriers excels at same-day and scheduled deliveries, the company also has its sights set on innovative solutions that further refine the customer experience. In line with its commitment to high-quality service, Drift Couriers is developing an on-demand van booking app called “Courier Near Me App,” which is slated for release in the near future. Modelled after popular ride-hailing apps, this platform will allow businesses and individuals to schedule and track shipments in real time seamlessly. Users will be able to see the exact location of their assigned driver, reducing uncertainty around arrival times.

In addition to new technology, the company is continually refining its business model to accommodate the changing demands of modern commerce. By combining a reliable local courier service with a robust nationwide same-day courier service, Drift Couriers can handle small enterprises’ immediate delivery needs while accommodating large-scale, recurring shipments for national corporations. This dual approach ensures that each client receives a tailored solution, whether they send parcels daily or once a month. Furthermore, the company’s drivers are trained to adapt on the fly, guaranteeing that unexpected conditions—such as road closures or last-minute route changes—are addressed with minimal disruption.

Drift Couriers’ success is also built on a foundation of dedicated customer service. Representatives engage directly with clients to understand each project’s unique requirements, offering guidance on vehicle selection and scheduling. That personal touch helps businesses navigate potential obstacles, whether determining how to transport fragile materials best or strategizing an optimal multi-drop route. Clients who work with Drift Couriers often praise the company’s attention to detail and how efficiently each concern is handled.

As for cost-effectiveness, Drift Couriers prides itself on providing affordable services rather than branding itself as the most affordable on the market. The company firmly believes that affordability should not come at the expense of quality and reliability. Drift Couriers can keep costs under control by optimizing routes, consolidating packages, and investing in intelligent dispatch software while maintaining exceptional service standards.

For companies that require guaranteed reliability, swift turnarounds, and an approach tailored to unique operational demands, Drift Couriers remains a proven solution. From urgent delivery requests to regularly scheduled shipments, the company’s proven track record, forward-thinking initiatives, and strong emphasis on sustainability reinforce its position as a leader in modern logistics.

Media Contact
Company Name: Drift Couriers
Contact Person: Daniel Scott
Email: Send Email
Country: United Kingdom
Website: https://www.driftsamedaycouriers.co.uk

Kris Thorkelson Shares Entrepreneurial Journey in Exclusive Online Interview

Kris Thorkelson, the CEO and owner of Thorwin Properties, is excited to share insights into his entrepreneurial journey in a new online interview. The interview highlights Kris’s transition from pharmacy to real estate, his approach to business growth, and his commitment to community-focused initiatives.

Starting with his education at the University of Manitoba, Kris reflects on his early career in the pharmacy industry, where he co-owned multiple pharmacies. However, in 2010, he made a strategic pivot to real estate, founding Thorwin Properties. Over the years, Kris has successfully grown his company’s portfolio to manage over 2,400 apartment units across Winnipeg, with a strong focus on providing high-quality housing and outstanding resident service.

In the interview, Kris shares the key decisions that shaped his path, including his shift from pharmacy to real estate, and how his commitment to long-term growth has been central to his success. He also discusses his philanthropic efforts, including his $500,000 donation to the University of Manitoba’s Pharmacy faculty and his support for various global and local causes.

“Entrepreneurship is about taking calculated risks and being adaptable,” says Kris Thorkelson. “I’m grateful for the experiences that have shaped me, and I hope my story can inspire others to follow their passions and embrace opportunities for growth.”

Kris also touches on the importance of leadership, team-building, and fostering a culture of care within his business. He emphasizes how these elements have contributed to the continued success of Thorwin Properties, helping the company stand out in Winnipeg’s competitive real estate market. His interview provides valuable insights for aspiring entrepreneurs looking to navigate the challenges of business ownership and personal growth.

To read the full interview and gain valuable insights into Kris’s entrepreneurial journey, visit the website here.

Media Contact
Contact Person: Kris Thorkelson
Email: Send Email
City: Winnipeg
State: Manitoba
Country: Canada
Website: kristhorkelson.com